Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting, 36191 [05-12233]

Download as PDF Federal Register / Vol. 70, No. 119 / Wednesday, June 22, 2005 / Notices III. Paperwork Reduction Act of 1995 This revised final guidance contains information collection provisions that are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3520). The collection of information in this guidance was approved under OMB control number 0910–0509. The approval expires on December 31, 2006. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. IV. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) written or electronic comments regarding this revised guidance at any time. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The revised guidance and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. V. Electronic Access Persons with access to the Internet may obtain the revised guidance document at http://www.cfsan.fda.gov/ guidance.html. Dated: June 13, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05–12234 Filed 6–21–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC). Dates and Times: July 21, 2005, 9 a.m. to 5 p.m., and July 22, 2005, 9 a.m. to 3 p.m. Place: Ronald Reagan Building and International Trade Center, Rotunda Room, VerDate jul<14>2003 21:12 Jun 21, 2005 Jkt 205001 1300 Pennsylvania Avenue, NW., Washington, DC 20004. Status: The meeting will be open to the public with attendance limited to space availability. Purpose: The Advisory Committee provides advice and recommendations concerning the grants and projects authorized under the Heritable Disorders Program and technical information to develop policies and priorities for this program that will enhance the ability of the State and local health agencies to provide for newborn and child screening, counseling and health care services for newborns and children having or at risk for heritable disorders. Specifically, the Advisory Committee shall advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. Agenda: Presentations and discussions will include: an update on the American College of Medical Genetics report; the role of evidence and other factors in decisionmaking; the status of newborn screening in States; the newborn screening policy of the American College of Obstetrics and Gynecology; and reports from the Subcommittees on Education and Training, Treatment and Follow-up, and Laboratory Standards and Procedures. Proposed agenda items are subject to change as priorities indicate. Public Comments: Time will be provided each day for public comment. Written comments should be submitted no later than July 14, 2005. Individuals who wish to provide public comment or who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the ACHDGDNC Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–1080. For Further Information Contact: Anyone interested in obtaining a roster of members or other relevant information should write or contact Jill Shuger, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–1080. Information on the Advisory Committee is available at http:// mchb.hrsa.gov/programs/genetics/committee. Dated: June 16, 2005. Tina M. Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. 05–12233 Filed 6–21–05; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 36191 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would institute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Aging Special Emphasis Panel HRS. Date: June 29–30, 2005. Time: 6:15 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Alfonso R. Latoni, PhD, Health Scientist Administrator, Scientific Review Office, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Room 2C212, Bethesda, MD 20892, 301–402–7707, latonia@nia.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Aging Special Emphasis Panel; Alzheimer Trials. Date: July 8, 2005. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Gateway Building, 7201 Wisconsin Ave, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ramesh Vemuri, PhD, Health Scientist Administrator, Scientific Review Office, National Institute on Aging, National Institutes of Health, Room 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7700, rv23r@nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; Long Term Care. Care: July 10–11, 2005. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jon Rolf, PhD, Health Scientist Administrator, Scientific Review E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 70, Number 119 (Wednesday, June 22, 2005)]
[Notices]
[Page 36191]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-12233]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders and Genetic Diseases in 
Newborns and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Committee on Heritable Disorders and Genetic 
Diseases in Newborns and Children (ACHDGDNC).
    Dates and Times: July 21, 2005, 9 a.m. to 5 p.m., and July 22, 
2005, 9 a.m. to 3 p.m.
    Place: Ronald Reagan Building and International Trade Center, 
Rotunda Room, 1300 Pennsylvania Avenue, NW., Washington, DC 20004.
    Status: The meeting will be open to the public with attendance 
limited to space availability.
    Purpose: The Advisory Committee provides advice and 
recommendations concerning the grants and projects authorized under 
the Heritable Disorders Program and technical information to develop 
policies and priorities for this program that will enhance the 
ability of the State and local health agencies to provide for 
newborn and child screening, counseling and health care services for 
newborns and children having or at risk for heritable disorders. 
Specifically, the Advisory Committee shall advise and guide the 
Secretary regarding the most appropriate application of universal 
newborn screening tests, technologies, policies, guidelines, and 
programs for effectively reducing morbidity and mortality in 
newborns and children having or at risk for heritable disorders.
    Agenda: Presentations and discussions will include: an update on 
the American College of Medical Genetics report; the role of 
evidence and other factors in decisionmaking; the status of newborn 
screening in States; the newborn screening policy of the American 
College of Obstetrics and Gynecology; and reports from the 
Subcommittees on Education and Training, Treatment and Follow-up, 
and Laboratory Standards and Procedures.
    Proposed agenda items are subject to change as priorities 
indicate.
    Public Comments: Time will be provided each day for public 
comment. Written comments should be submitted no later than July 14, 
2005. Individuals who wish to provide public comment or who plan to 
attend the meeting and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the ACHDGDNC Executive Secretary, Michele A. Lloyd-Puryear, 
M.D., Ph.D., Maternal and Child Health Bureau, Health Resources and 
Services Administration, Room 18A-19, Parklawn Building, 5600 
Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443-1080.
    For Further Information Contact: Anyone interested in obtaining 
a roster of members or other relevant information should write or 
contact Jill Shuger, Maternal and Child Health Bureau, Health 
Resources and Services Administration, Room 18A-19, Parklawn 
Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone 
(301) 443-1080. Information on the Advisory Committee is available 
at http://mchb.hrsa.gov/programs/genetics/committee.

    Dated: June 16, 2005.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. 05-12233 Filed 6-21-05; 8:45 am]
BILLING CODE 4165-15-P